Involvement of hypoxia-inducible factor-1-alpha in multidrug resistance induced by hypoxia in HepG2 cells.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of experimental & clinical cancer research : CR

• Publication date

  2005-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 16471319
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Resveratrol-induced Autophagocytosis in Ovarian Cancer Cells

  2004cited by this paper
• A Pivotal Role of Cyclic AMP-Responsive Element Binding Protein in Tumor Progression

  2004cited by this paper
• Hypoxia-inducible factor-1 in tumour angiogenesis.

  2004cited by this paper
• Regulation of Hypoxia-inducible Factor-1α Protein Level during Hypoxic Conditions by the Phosphatidylinositol 3-Kinase/Akt/Glycogen Synthase Kinase 3β Pathway in HepG2 Cells*

  2003cited by this paper
• Investigating hypoxic tumor physiology through gene expression patterns

  2003cited by this paper
• Targeting HIF-1 for cancer therapy

  2003cited by this paper
• Mechanisms of Hypoxic Gene Regulation of Angiogenesis Factor Cyr61 in Melanoma Cells*

  2003cited by this paper
• The hypoxia-inducible factors: key transcriptional regulators of hypoxic responses

  2003cited by this paper
• Multidrug resistance mediated by the breast cancer resistance protein BCRP (ABCG2)

  2003cited by this paper
• Chemoembolization in the management of liver tumors.

  2003cited by this paper
• Strategies for reversing drug resistance

  2003cited by this paper
• Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies.

  2003cited by this paper
• Regulation of angiogenesis by hypoxia: role of the HIF system

  2003cited by this paper
• Expression of the inhibitor of apoptosis (IAP) family members in human neutrophils: up-regulation of cIAP2 by granulocyte colony-stimulating factor and overexpression of cIAP2 in chronic neutrophilic leukemia.

  2003cited by this paper
• Measurement of chemoresistance markers in patients with stage III non-small cell lung cancer: a novel approach for patient selection.

  2003cited by this paper
• Multidrug resistance and pharmacological protection mediated by the breast cancer resistance protein (BCRP/ABCG2).

  2002cited by this paper
• Reversal of drug resistance of hepatocellular carcinoma cells by adenoviral delivery of anti‐MDR1 ribozymes

  2002cited by this paper
• Expression of the lung resistance-related protein in human and rat hepatocarcinogenesis.

  2002cited by this paper
• Cellular adaptation to hypoxia: O2‐sensing protein hydroxylases, hypoxia‐inducible transcription factors, and O2‐regulated gene expression

  2002cited by this paper
• Genetic mechanisms of hepatocarcinogenesis

  2002cited by this paper
• Hypoxia-induced angiogenesis in human hepatocellular carcinoma

  2002cited by this paper
• Epidemiology and clinical presentation of hepatocellular carcinoma.

  2002cited by this paper
• Epidemiology, Risk Factors, and Natural History of Hepatocellular Carcinoma

  2002cited by this paper
• Identification of small molecule inhibitors of hypoxia-inducible factor 1 transcriptional activation pathway.

  2002cited by this paper
• Mitogen-activated Protein Kinase p38 Mediates Regulation of Chondrocyte Differentiation by Parathyroid Hormone*

  2001cited by this paper
• A novel strategy for human papillomavirus detection and genotyping with SybrGreen and molecular beacon polymerase chain reaction.

  2001cited by this paper
• Cell adhesion is a key determinant in de novo multidrug resistance (MDR): new targets for the prevention of acquired MDR.

  2001cited by this paper
• Attenuation of HIF-1 DNA-binding activity limits hypoxia-inducible endothelin-1 expression

  2001cited by this paper
• Hypoxia Regulation of Gene Transcription

  2001cited by this paper
• Hepatocellular carcinoma.

  2001cited by this paper
• Hypoxia, Clonal Selection, and the Role of HIF-1 in Tumor Progression

  2000cited by this paper
• Carcinogenic nickel induces genes involved with hypoxic stress.

  2000cited by this paper
• Hypoxia modulated gene expression: angiogenesis, metastasis and therapeutic exploitation.

  2000cited by this paper
• Multidrug resistance-associated protein subfamily transporters and drug resistance.

  1999cited by this paper
• Epidemiology of Primary Liver Cancer

  1999cited by this paper
• Reoxygenation of hypoxic human umbilical vein endothelial cells activates the classic complement pathway.

  1997cited by this paper
• Epithelial exposure to hypoxia modulates neutrophil transepithelial migration

  1996cited by this paper
• Protein measurement with the Folin phenol reagent.

  1951cited by this paper

• Development of small molecule inhibitors of hypoxia-inducible factors for cancer therapy.

  2025cites this paper
• Hypoxia as a Target for Combination with Transarterial Chemoembolization in Hepatocellular Carcinoma

  2024cites this paper
• Oncofetal reprogramming in tumor development and progression: novel insights into cancer therapy

  2023cites this paper
• Functional Imaging of Hypoxia: PET and MRI

  2023cites this paper
• Research progress on the role of TGF-β in regulating the microenvironment of hepatocellular carcinoma and multidrug resistance

  2023cites this paper
• Mitochondrial ROS drive resistance to chemotherapy and immune-killing in hypoxic non-small cell lung cancer

  2022cites this paper
• Multidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches

  2022cites this paper
• Notch1 signaling modulates hypoxia-induced multidrug resistance in human laryngeal cancer cells

  2022cites this paper
• Notch1 Signaling Modulates Hypoxia-induced Multidrug Resistance of Human Laryngeal Cancer Cells

  2021cites this paper
• Hypoxia, endoplasmic reticulum stress and chemoresistance: dangerous liaisons

  2021influential citation
• Hypoxia as a driver of resistance to immunotherapy.

  2021cites this paper
• Radio-sensitivity enhancement in HT29 cells through magnetic hyperthermia in combination with targeted nano-carrier of 5-Flourouracil.

  2021cites this paper
• Current perspectives on the tumor microenvironment in hepatocellular carcinoma

  2020cites this paper
• Low oxygen tension differentially regulates the expression of placental solute carriers and ABC transporters

  2020cites this paper
• Glucose Metabolism and Oxidative Stress in Hepatocellular Carcinoma: Role and Possible Implications in Novel Therapeutic Strategies

  2020cites this paper
• Molecular Bases of Drug Resistance in Hepatocellular Carcinoma

  2020influential citation
• Hyperbaric oxygen and radiation therapy: a review

  2020cites this paper
• Hypoxia Mediates Tumor Malignancy and Therapy Resistance.

  2019cites this paper
• Molecular bases of the poor response of liver cancer to chemotherapy.

  2018cites this paper
• Seven shades of tamoxifen resistance : Molecular mechanisms of drug resistance in breast cancer

  2018cites this paper
• Hypoxia in Tumor Microenvironment and Chemotherapy Resistance

  2018cites this paper
• 6 Anticancer Drug Metabolism : Chemotherapy Resistance and New Therapeutic Approaches

  2018cites this paper
• Drug resistance and cancer stem cells: the shared but distinct roles of hypoxia‐inducible factors HIF1α and HIF2α

  2017cites this paper
• A hemoglobin-based oxygen carrier sensitized Cisplatin based chemotherapy in hepatocellular carcinoma

  2017cites this paper
• Histone deacetylase 5 promotes the migration and invasion of hepatocellular carcinoma via increasing the transcription of hypoxia-inducible factor-1α under hypoxia condition

  2017cites this paper
• Hypoxia as a target for drug combination therapy of liver cancer

  2017cites this paper
• Further understanding of mechanisms involved in liver cancer chemoresistance

  2017cites this paper
• Title A hemoglobin-based oxygen carrier sensitized Cisplatin basedchemotherapy in hepatocellular carcinoma

  2017cites this paper
• Therapeutic prospects of microRNAs in cancer treatment through nanotechnology

  2017cites this paper
• The effect of ALA-PDT under normoxia and cobalt chloride (CoCl2)-induced hypoxia on adhesion molecules (ICAM-1, VCAM-1) secretion by colorectal cancer cells.

  2017cites this paper
• Secretory Stanniocalcin 1 promotes metastasis of hepatocellular carcinoma through activation of JNK signaling pathway.

  2017cites this paper
• Targeting the vasculature in hepatocellular carcinoma treatment: Starving versus normalizing blood supply

  2017cites this paper
• Analysis of angiogenesis related factors in glioblastoma, peritumoral tissue and their derived cancer stem cells

  2016cites this paper
• Effect of multidrug resistance 1/P-glycoprotein on the hypoxia-induced multidrug resistance of human laryngeal cancer cells.

  2016cites this paper
• Selective GPR55 antagonism reduces chemoresistance in cancer cells.

  2016cites this paper
• MiR-183 modulates multi-drug resistance in hepatocellular cancer (HCC) cells via miR-183-IDH2/SOCS6-HIF-1α feedback loop.

  2016cites this paper
• Novel molecular triggers underlie valproate-induced liver injury and its alleviation by the omega-3 fatty acid DHA: role of inflammation and apoptosis

  2016influential citation
• Expression of multidrug resistance protein P-glycoprotein in correlation with markers of hypoxia (HIF-1α, EPO, EPO-R) in invasive breast cancer with metastasis to lymph nodes

  2016cites this paper
• Impact on angiogenesis and ER stress and its effect on chemoresistance through PlGF inhibition in a mouse model of hepatocellular carcinoma

  2015cites this paper
• Resistance to cancer chemotherapy: failure in drug response from ADME to P-gp

  2015cites this paper
• Hypoxia inducible factor in hepatocellular carcinoma: A therapeutic target.

  2015cites this paper
• Therapeutic effects of artesunate in hepatocellular carcinoma: repurposing an ancient antimalarial agent

  2014cites this paper
• Three-dimensional in vitro tumor models for cancer research and drug evaluation.

  2014cites this paper
• A hydrogel-based tumor model for the evaluation of nanoparticle-based cancer therapeutics.

  2014cites this paper
• Hypoxia-regulated gene network in drug resistance and cancer progression

  2014cites this paper
• Sphingosine-1-Phosphate in Hypoxic Signaling

  2014cites this paper
• Hypoxia-induced tumor malignancy and drug resistance: Role of microRNAs

  2014cites this paper
• A Mechanism of Regulation of Hypoxia-Inducible Factor 1 Alpha by Nitric Oxide

  2014cites this paper
• Single-cell pharmacokinetic imaging reveals a therapeutic strategy to overcome drug resistance to the microtubule inhibitor eribulin

  2014cites this paper
• Hypoxia induced multidrug resistance of laryngeal cancer cells via hypoxia-inducible factor-1α.

  2013influential citation
• Drug metabolism and transport under hypoxia.

  2013cites this paper
• Antitumor and chemosensitizing action of dichloroacetate implicates modulation of tumor microenvironment: a role of reorganized glucose metabolism, cell survival regulation and macrophage differentiation.

  2013cites this paper
• Targeting monocarboxylate transporter by α-cyano-4-hydroxycinnamate modulates apoptosis and cisplatin resistance of Colo205 cells: implication of altered cell survival regulation

  2013cites this paper
• pH-sensitive pullulan-based nanoparticle carrier of methotrexate and combretastatin A4 for the combination therapy against hepatocellular carcinoma.

  2013cites this paper
• Hypoxia-inducible factor-1alpha: molecular-targeted therapy for hepatocellular carcinoma.

  2013cites this paper
• Hypoxia-regulated microRNAs in human cancer

  2013cites this paper
• Hypoxia, therapeutic resistance, and sphingosine 1-phosphate.

  2013influential citation
• Induktionschemotherapie bei hepatozellulären Karzinomen

  2013cites this paper
• Novel antiangiogenic therapies against advanced hepatocellular carcinoma (HCC)

  2012cites this paper
• Microparticle conferred microRNA profiles - implications in the transfer and dominance of cancer traits

  2012cites this paper
• Topics on Drug Metabolism

  2012cites this paper
• Effect of environmental factors on chemoresistance of HepG2 cells by regulating hypoxia-inducible factor-1α.

  2012cites this paper
• Discovery of small-molecule natural products that target cellular bioenergetics

  2012cites this paper
• Serum vascular endothelial growth factor as a predictor of response and survival in patients with advanced hepatocellular carcinoma undergoing hepatic arterial infusion chemotherapy

  2012cites this paper
• Curcumin resistance induced by hypoxia in HepG2 cells is mediated by multidrug-resistance-associated proteins.

  2012cites this paper
• Anticancer Drug Metabolism: Chemotherapy Resistance and New Therapeutic Approaches

  2012cites this paper
• Pseudolaric acid B-driven phosphorylation of c-Jun impairs its role in stabilizing HIF-1alpha: a novel function-converter model

  2012cites this paper
• Hypoxia as a Target for Drug Combination Therapy of Liver Cancer A thesis submitted in partial fulfilment of the requirements of the University of Brighton for the degree of Doctor of Philosophy

  2012cites this paper
• Expression Characteristics of Hypoxia-Inducible Factor-1α and Its Clinical Values in Diagnosis and Prognosis of Hepatocellular Carcinoma

  2011cites this paper
• Various doses of fractioned irradiation modulates multidrug resistance 1 expression differently through hypoxia-inducible factor 1α in esophageal cancer cells.

  2011cites this paper
• Rôle des protéines de choc thermique dans la régulation du facteur de transcription HIF

  2011cites this paper
• Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways.

  2011cites this paper
• Mechanism of Hypoxia-Inducible Factor-1alpha Over- Expression and Molecular-Target Therapy for Hepatocellular Carcinoma

  2011cites this paper
• Chronic Hypoxia Emerging as One of the Driving Forces behind GeneExpression and Prognosis of Hepatocellular Carcinoma

  2011cites this paper
• Induction Chemotherapy for Hepatocellular Carcinoma

  2011cites this paper
• The status of Chinese medicine in reversing multi-drug resistance of hepatocellular carcinoma

  2011cites this paper
• Expression of MDR1, HIF-1α and MRP1 in sacral chordoma and chordoma cell line CM-319

  2010cites this paper
• Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

  2010cites this paper
• Regulation of hepatic ABCC transporters by xenobiotics and in disease states

  2010cites this paper
• Hypoxia in Brain Tumors: A Review of the Literature

  2009cites this paper
• [Hypoxia in cancer malignity. Review].

  2009cites this paper
• Hipoxia en la malignidad del cáncer. Revisión.

  2009cites this paper
• Drug-metabolising enzymes are down-regulated by hypoxia in differentiated human hepatoma HepaRG cells: HIF-1alpha involvement in CYP3A4 repression.

  2009cites this paper
• Effect of Hypoxia-inducible Factor-1α Silencing on the Sensitivity of Human Brain Glioma Cells to Doxorubicin and Etoposide

  2009cites this paper
• Chemotherapy and Novel Systemic Therapies

  2009cites this paper
• BIOCHEMICAL CHARACTERIZATION OF NUCLEOTIDE AND PROTEIN INTERACTIONS OF HUMAN MULTIDRUG RESISTANCE PROTEIN 1 (MRP1/ABCC1)

  2008cites this paper
• New strategy of antiangiogenic therapy for hepatocellular carcinoma.

  2008cites this paper
• Molecular targeted therapy for hepatocellular carcinoma

  2008cites this paper
• Systemic Therapy for Hepatocellular Carcinoma: Cytotoxic Chemotherapy, Targeted Therapy and Immunotherapy

  2008cites this paper
• Role of hypoxia-inducible factor-alpha in hepatitis-B-virus X protein-mediated MDR1 activation.

  2007cites this paper
• Hypoxia upregulates carcinoembryonic antigen expression in cancer cells

  2007cites this paper
• A two-phase strategy for treatment of oxidant-dependent cancers.

  2007cites this paper
• Hypoxia and hepatocellular carcinoma: The therapeutic target for hepatocellular carcinoma

  2007cites this paper